Associate
Kyle Howarth focuses on patent and trade secret litigation relating to a wide array of technologies in the chemical field. He is involved in proceedings before U.S. district courts (including Abbreviated New Drug Application (ANDA) litigation), investigations before the U.S. International Trade Commission (ITC), and post-grant trial proceedings at the U.S. Patent and Trademark Office (USPTO).
Kyle’s litigation experience includes developing infringement and invalidity theories; conducting fact and expert discovery, including depositions; drafting briefs and motions; and participating at trial. His work helps protect and defend clients’ valuable innovations relating to catalysts and coating technologies, semiconductors, polymer science, medical devices, pharmaceuticals, and gene therapy treatments, among other related technologies.
While in law school, Kyle worked at Finnegan as a summer associate. He also published in the Duke Law Journal a Note, “Carrots, Sticks, and Space Patents,” which proposed solutions to potential problems with the current framework for patents in outer space.
Kyle has a background in fluid mechanics and material science stemming from his degree in chemical engineering. Prior to law school, he conducted research aimed at improving space enabling operations, working in a lab funded by the National Aeronautics and Space Administration (NASA). Specifically, his research included studying resonance pattern formation in microfluids and electrostatic-levitated particles with the goal of creating improved heat exchangers in low-gravity environments and developing enhanced material properties in metals. In addition to collaborating with researchers at NASA, Kyle coordinated with international researchers in France and Japan and was awarded a scholarship to conduct his research at the University of Lille in France.
Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.
Represented Rocket Pharmaceuticals, Inc. in district court litigation involving claims of trade secret misappropriation and breach of contract against individual and corporate defendants and relating to complex treatments for genetic disorders. Successfully opposed motion to dismiss key claims and obtained settlement with all defendants following completion of fact discovery.
1:23-cv-09000, S.D.N.Y., Judges Castel, Aaron
CMC Materials, LLC v. Dupont de Nemours, Inc. et al.
1:20-cv-00738, D. Del., Judge Hall
Articles
Patent Law's On-Sale Bar and Commercial Exploitation by Suppliers and Third Parties Patent Law's On-Sale Bar and Commercial Exploitation by Suppliers and Third Parties
March 21, 2025
ReutersArticles
The On-Sale Bar and Commercial Exploitation by Patentees The On-Sale Bar and Commercial Exploitation by Patentees
March 13, 2025
Reuters*Admitted in Florida only; not admitted in Virginia.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.